SOFTMEDX (00648) announced that on May 7, 2026, the company was notified by the selling shareholder that all 500 million shares held by them, representing approximately 23.3% of the company's issued share capital as of the date of this announcement, have been placed by the placing agent. The placement price was HKD 0.11 per share, and the shares were placed to no fewer than six placees. To the best of the directors' knowledge, information, and belief, after making all reasonable enquiries, each placee and its ultimate beneficial owner(s) (if any) are independent third parties unconnected to the company and its connected persons. Furthermore, none of them have any connection or are acting in concert with the company or any of its connected persons. Following the completion of the placement, none of the placees became a major shareholder of the company. After the placement, the selling shareholder's interest in the company decreased from 74.4% to 51.0%, and they remain the company's controlling shareholder. The company does not expect the placement to have any adverse impact on the business operations of the company and its subsidiaries.
Comments